Telangana DCA seizes Rs 4.05 Cr worth of spurious anti-cancer drugs
Govt puts forward "Bio-Vision" for Bharat at BRIC Society's Maiden Meeting
Karnataka government unveils draft of Biotechnology policy 4.0
Lord’s Mark Industries aims to go public in 2024 with plans to raise up to Rs 500 Cr
Vibcare Healthcare opens pharma manufacturing facility with Rs 40 Cr investment in Panchkula
Fortis Healthcare to divest Fortis Malar Hospital, Chennai to MGM Healthcare for Rs 128 Cr
Indian Immunologicals unveils Measles and Rubella vaccine for children
Sanjivani Paranteral and Hindustan Antibiotics collaborate to manufacture IV formulations and IV sets
Novo Nordisk invests Kr. 42 B+ for expansion of manufacturing facilities in Denmark
US FDA approves first gene therapies to treat patients with sickle cell disease
New research shows failure of current policies to eradicate TB
Roche launches automated serology hepatitis E virus tests
Science | 07 December 2023 | News
Merck announces winners of Young Scientist Award 2023
Merck, a leading science and technology company, has announced the winners of Merck Young Scientist ...Read more
Opinion | 07 December 2023 | Views
Navigating Digital Evolution: Transforming HCP-Pharma Interactions for the Future
The biopharmaceutical industry is constantly transforming in the digital age, driven by the need for innovatio...Read more
MedTech | 08 December 2023 | News
Harmonising Indian regulations with global best practices to propel India’s MedTech sector
The Medical Technology Association of India (MTaI), which represents leading research-based medical technology...Read more
Biotechnology | 08 December 2023 | News
Karnataka govt supports C-CAMP in launching Phase II of 2 major biotech innovation programmes
The Karnataka Innovation and Technology Society, (KITS) and the Department of Agriculture, Government of Karna...Read more
Supplier | 08 December 2023 | News
VFL Sciences launches Penguin Classic Laboratory Freeze Dryer /Lyophilizer
Chennai-based VFL Sciences Private Limited has announced the launch of Penguin Classic, Laboratory Freeze Drye...Read more
People | 07 December 2023 | News
Renowned diabetologist Dr V. Mohan receives prestigious Lakshmipat Singhania Award
Recognising outstanding contributions and exceptional leadership in Research on Diabetology, Dr V. Mohan, Chai...Read more
Academics | 21 November 2023 | News
Cloudnine signs MoU with British Association of Physicians of Indian Origin Training Academy
Cloudnine, India’s premium birthing centre for maternal and childcare, has signed a Memorandum of U...Read more
Text blogs | 15 November 2023 | Views
Education Must for Early Detection of Breast Cancer
Breast cancer (BC) is the most diagnosed type of cancer claiming the lives of more than 0.5 million women ever...Read more
From Exponential Growth to PHARMA BOOM
The Indian pharmaceutical industry is experiencing a dynamic growth landscape, marked by strategic initiatives such as partnerships, investments, Memoranda of Understanding (MoUs), and collaborations. Despite geopolitical uncertainties like the Israel-Palestine and Russia-Ukraine conflicts lingering in 2023, the healthcare and pharma sector in India continues to gain momentum through new investments and collaborative efforts. Major global players are actively engaging in partnerships, MoUs, and collaborations to secure a substantial global market share. In 2023 alone, more than 30 partnerships, MoUs and other collaborations have been forged to boost India’s pharmaceutical growth trajectory. The Indian pharmaceutical products market is projected to hit $130 billion by the end of 2030.
For Feedback, please email us at: communications@mmactiv.com
Ashirwad Bungalow, First floor,
36/A/2, S.No. 270, Pallod Farms,
Near Bank of Baroda, Baner Road,
Pune, Maharashtra, India 411045
Mob : +91-9579069369
Email : communications@mmactiv.com
